Evidence map›Paper›PMID 39115664›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2024

Methods for Monitoring Mitophagy Using mt-Keima.

Alexandra J Gilsrud, Derek P Narendra

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Alexandra J GilsrudInherited Movement Disorders Unit, Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, Division of Intramural Research, National Institutes of Health, Bethesda, MD, USA.
Derek P NarendraInherited Movement Disorders Unit, Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, Division of Intramural Research, National Institutes of Health, Bethesda, MD, USA. derek.narendra@nih.gov.

Funding

Mitochondrial stress responses in neurodegenerationZIANS003169 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI NARENDRA, DEREK · 2019 to 2025
$18.3M
Intramural NIH HHS ZIA NS003169
6 · The paper itself

Abstract

Mitochondria-targeted Keima (mt-Keima) is a pH-sensitive, acid-stable fluorescent protein used for the quantification of mitophagy. Mt-Keima contains a mitochondrial matrix targeting sequence and has bimodal excitation with peaks at 440 nM in neutral environments and 586 nM in acidic environments. From this bimodal excitation, a ratiometric signal may be calculated to quantify mitophagy in live cells. This chapter describes procedures for measuring mitophagy by flow cytometry and live cell confocal microscopy with mt-Keima.

Indexed as

Flow CytometryMicroscopy, ConfocalMitochondriaMitophagyHeLa CellsHumansHydrogen-Ion ConcentrationLuminescent ProteinsLuminescent ProteinsMitochondriaMitophagyParkinPINK1Selective autophagy

Identifiers

PMID39115664

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.